(Q40678643)

22 September 2017

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy (English)

1 reference

22 September 2017

O. P. Purohit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

19 May 2024

C. R. Radstone

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

19 May 2024

C. Anthony

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

19 May 2024

J. A. Kanis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

19 May 2024

R. E. Coleman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

19 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

PMC publication ID

2033943

full work available at URL

22 September 2017

https://www.nature.com/articles/bjc1995502.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

https://europepmc.org/articles/PMC2033943

19 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

https://europepmc.org/articles/PMC2033943?pdf=render

19 May 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577484

http://www.nature.com/articles/bjc1995502.pdf

19 May 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1995.502

http://www.nature.com/articles/bjc1995502

19 May 2024

1 reference

https://api.crossref.org/works/10.1038/BJC.1995.502

British Journal of Cancer

19 May 2024

published in

1 reference

22 September 2017

72

1 reference

22 September 2017

5

1 reference

22 September 2017

1289-1293

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.502

22 September 2017

0 references

cites work

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Tumour induced hypercalcaemia: a case for active treatment

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

High-dose intravenous pamidronate for metastatic bone pain

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Analysis of serial measurements in medical research

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033943

Hypercalcaemia--a hospital survey

15 June 2018

1 reference

12 December 2020

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia

1 reference

12 December 2020

Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP

1 reference

12 December 2020

Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia

1 reference

12 December 2020

Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia

1 reference

12 December 2020

Renal failure associated with intravenous diphosphonates

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.502

1 reference

22 September 2017

1 reference

PMC publication ID

2033943

22 September 2017

1 reference

PMC publication ID

2033943